Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q3 2016 Earnings

9AugConfirmed

Q4 2015

Q1 2016

Q2 2016

Q3 2016

-0.28

-0.18

-0.07

0.03

Details

Expected EPS

-0.28

Actual EPS

-0.21

Surprise EPS

0.07

Surprise Percent

+25%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.21 per share for Q3 2016.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.